Shannon R. McCurdy, MD
Hematology
Headshot of Shannon R. McCurdy, MD

Shannon R. McCurdy, MD

Hematology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 4th Floor West
Headshot of Shannon R. McCurdy, MD
Penn Medicine Provider

About me

  • Associate Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania

My education and training

  • Georgetown University School of MedicineMedical School
  • University of Pennsylvania Health SystemResidency
  • Johns Hopkins HospitalFellowship

Spoken languages

English
English

Reviews

Average Rating

314 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
September 2026
Excellent medical advice
Anonymous
September 2026
Clearly explained the Pathology and the recommendatio for Recovery
Anonymous
September 2026
Extremely well done
Anonymous
September 2026
Dr McCurdy was very thorough.. she explained my cancer to me, made hand written notes so that I could take them home and refer to them. She did a very thorough history, LISTENED to my questions and gave thorough, understandable answers. She was excellent.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. McCurdy is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Sallman DA, Garcia-Manero G, Daver N, Abboud CN, Stein E, Larkin K, Halpern AB, McCurdy SR, Al Malki MM, Subramanian Guru Murthy G, Silverman LR, Larson RA, Greenberg P, Gojo I, Wrobel T, Platzbecker U, Forsyth C, Vachhani P, Dong M, Shao J, Johnson LDS, Tan A, Lee C, Doshi P, Vyas P, Wei AH. Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study , J Clin Oncol: 2026


Aljawai Y, Nawas M, McCurdy S, Kanakry CG, Kanakry JA, Rimando JC, Saultz J, Al-Juhaishi T, Lazaryan A, Milano F, Mehta RS. Absolute risk trade-offs of donor age, sex, and graft source in PTCy-based transplantation , Blood Adv, 10: 2026,4884-4888


McCurdy SR, Azar H, Beldi-Ferchiou A. Editorial: NK cells in transplantation , Front Immunol, 17: 2026,1882415


Cusatis R, Kou J, Bupp C, Mattila D, Abboud R, Arai S, Bolaños Meade J, Carrum G, Dholaria B, Fareh F, Hamadani M, Hogan WJ, Jamieson K, Jimenez Jimenez AM, Khimani F, Kelkar AH, Kosuri S, Larkin KT, Al Malki MM, McCurdy SR, Milner J, Modi D, Reshef R, Shaffer BC, Shanmugasundaram K, Rao U, Auletta JJ, Devine SM, Logan BR, Shaw BE. Hematopoietic Cell Transplant Access and Patient Diversity , JAMA Netw Open, 9: 2026,e2610839


Mehta RS, Kanakry CG, Nawas M, Lazaryan A, Kanakry JA, Holtan S, Al-Juhaishi T, Rimando JC, Singh A, Saultz J, Mccurdy SR, Milano F. Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age , Leukemia: 2026


Mehta RS, McCurdy SR, Milano F, Nawas M, Aljawai Y, Rimando JC, Al-Juhaishi T, Im A, Kanakry JA, Lazaryan A, Kanakry CG. Challenging a clinical dogma with multimodal machine learning: a retrospective analysis of transplant mismatched donor selection , Leukemia: 2026


Artz AS, Logan B, Saber W, Geller N, Bellach A, Kou J, Wood WA, McCarty JM, Knight TG, Runaas L, Johnston L, Walston J, Nakamura R, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris L, Imus P, Hogan WJ, Nadiminti K, Bhatt VR, Olin R, Maakaron J, Sobecks R, Wall S, Mattila D, Protz B, Devine SM, Horowitz MM, Sorror ML. CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study , Blood Adv, 10: 2026,1657-1669


Kang Y, Lefebvre B, Smith A, Koropeckyj-Cox D, Brahmbhatt P, Ky B, Carver J, McCurdy S, Luger S, Scherrer-Crosbie M. Major Adverse Cardiovascular Events and Cardiac Dysfunction in Patients With Acute Leukemia: A Prospective Study , JACC CardioOncol: 2026


Shannon R. McCurdy, Scott R. Solomon, Brian C. Shaffer, Meilun He, Yung-Tsi Bolon, Amanda G. Blouin, Alla Keyzner, Francisco A. Socola, Uroosa Ibrahim, Jun Zou, Hana Safah, Nakhle Saba, Shahinaz Gadalla, Miguel-Angel Perales, Sophie Paczesny, Steven G.E. Marsh, Effie W. Petersdorf, Tao Wang, Stephanie J. Lee, Ephraim J. Fuchs Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation , Journal of Transplantation and Cellular Therapy, 32(1): 2026,74.e1


Nikita Dave, Shannon Gier, Marni Kessler, Miguel Rodriguez, Stefan Barta, Elise Chong, Adam Cohen, Noelle Frey, Saar Gill, Shannon Heck, Elizabeth Hexner, Nasheed Hossain, Shivani Kapur, Daniel Landsburg, Alison Loren, Selina Luger, Mary Ellen Martin, Pashna Munshi, Sunita Dwivedy Nasta, Alexander Perl, David Porter, Stephen Schuster, Edward Stadtmauer, Sandra Susanibar-Adaniya, Jakub Svoboda, Abby Togliatii, Dan Vogl, Adam Waxman, Daniel Wu, Shannon R. McCurdy Fried's frailty phenotype predicts survival in pts with relapsed/refractory lymphoma or myeloma undergoing chimeric antigen receptor T-cell therapy–a prospective, observational Study , American Society of Hematology Annual Meetings, Orlando, FL., 146: 2025,7189


View all publications